United States - English - NLM (National Library of Medicine)

xgen pharmaceuticals djb, inc. - clonidine hydrochloride (unii: w76i6xxf06) (clonidine - unii:mn3l5rmn02) - clonidine hydrochloride 100 ug in 1 ml - clonidine hydrochloride injection is indicated in combination with opiates for the treatment of severe pain in cancer patients that is not adequately relieved by opioid analgesics alone. epidural clonidine is more likely to be effective in patients with neuropathic pain than somatic or visceral pain (see clinical trials ). the safety of this drug product has only been established in a highly selected group of cancer patients, and only after an adequate trial of opioid analgesia. other use is of unproven safety and is not recommended. in a rare patient, the potential benefits may outweigh the known risks (see warnings ). clonidine hydrochloride injection is contraindicated in patients with a history of sensitization or allergic reactions to clonidine. epidural administration is contraindicated in the presence of an injection site infection, in patients on anticoagulant therapy, and in those with a bleeding diathesis. administration of clonidine hydrochloride injection above the c4 dermatome is contraindicated since there are no adequate safety data to support such use (see warnings ).

United States - English - NLM (National Library of Medicine)

sandoz inc - apraclonidine hydrochloride (unii: d2vw67n38h) (apraclonidine - unii:843cen85di) - apraclonidine 5.75 mg in 1 ml - apraclonidine ophthalmic solution 0.5% is indicated for short-term adjunctive therapy, in patients on maximally tolerated medical therapy, who require additional iop reduction. patients on maximally tolerated medical therapy, who are treated with apraclonidine ophthalmic solution 0.5% to delay surgery, should have frequent follow-up examinations and treatment should be discontinued if the iop rises significantly. the addition of apraclonidine ophthalmic solution 0.5% to patients already using two aqueous suppressing drugs (i.e., beta-blocker plus carbonic anhydrase inhibitor) as part of their maximally tolerated medical therapy may not provide additional benefit. this is because apraclonidine ophthalmic solution 0.5% is an aqueous suppressing drug and the addition of a third aqueous suppressant may not significantly reduce iop. the iop lowering efficacy of apraclonidine ophthalmic solution 0.5% diminishes over time in some patients. this loss of effect, or tachyphylaxis, appears to be an individual occurrence

United States - English - NLM (National Library of Medicine)

pharmaforce, inc. - clonidine hydrochloride (unii: w76i6xxf06) (clonidine - unii:mn3l5rmn02) - clonidine hydrochloride 100 ug in 1 ml - clonidine hydrochloride is indicated in combination with opiates for the treatment of severe pain in cancer patients that is not adequately relieved by opioid analgesics alone. epidural clonidine is more likely to be effective in patients with neuropathic pain than somatic or visceral pain (see clinical pharmacology, clinical trials). the safety of this drug product has only been established in a highly selected group of cancer patients, and only after an adequate trial of opioid analgesia. other use is of unproven safety and is not recommended. in a rare patient, the potential benefits may outweigh the known risks (see warnings). clonidine hydrochloride is contraindicated in patients with a history of sensitization or allergic reactions to clonidine. epidural administration is contraindicated in the presence of an injection site infection, in patients on anticoagulant therapy, and in those with a bleeding diathesis. administration of clonidine hydrochloride above the c4 dermatome is contraindicated since the

Canada - English - Health Canada

teva canada limited - clonidine hydrochloride - tablet - 0.025mg - clonidine hydrochloride 0.025mg - central alpha-agonists

Canada - English - Health Canada

mint pharmaceuticals inc - clonidine hydrochloride - tablet - 0.1mg - clonidine hydrochloride 0.1mg - central alpha-agonists

Canada - English - Health Canada

mint pharmaceuticals inc - clonidine hydrochloride - tablet - 0.2mg - clonidine hydrochloride 0.2mg - central alpha-agonists

Canada - English - Health Canada

marcan pharmaceuticals inc - clonidine hydrochloride - tablet - 0.025mg - clonidine hydrochloride 0.025mg

Canada - English - Health Canada

mint pharmaceuticals inc - clonidine hydrochloride - tablet - 0.025mg - clonidine hydrochloride 0.025mg

Canada - English - Health Canada

teva canada limited - clonidine hydrochloride - tablet - 0.1mg - clonidine hydrochloride 0.1mg - central alpha-agonists

Canada - English - Health Canada

teva canada limited - clonidine hydrochloride - tablet - 0.2mg - clonidine hydrochloride 0.2mg - central alpha-agonists